SAN FRANCISCO, Oct. 15 - Caliper Technologies said today it received $32.5 million from Aclara Biosciences as part of a settlement from 2001 litigation.
Â
Caliper will recognize $5 million of the payment as licensee fee revenue and $27.5 million as part of the settlement in its income statement, the company said.
Â
Caliper said it will also receive a minimum of $2.5 million as royalty payments by December 31 of 2002 and 2003 under terms of the settlement.
Â
In 2001, Caliper and Aclara settled lawsuits brought upon Aclara for infringing on lab-on-chip technology and Caliper for infringing on microfluidics methods. Previously, a jury granted Caliper $52 million in damages against Aclara for misappropriating its trade secrets, though this amount was reduced by a judge to $35 million.